Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Lawyer urges probe into Crans-Montana finances
WHO candidate Hanan Balkhy: ‘The bottom line is that the funding is slimmer' Read more: WHO candidate Hanan Balkhy: ‘The bottom line is that the funding is slimmer' Swiss components also found in new Russian weapons Read more: Swiss…
NewAmsterdam Pharma (NASDAQ:NAMS) Raised to Hold at Wall Street Zen
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) was upgraded by research analysts at Wall Street Zen from a 'sell' rating to a 'hold' rating in a report released on Sunday, Wall Street Zen reports. A number of other brokerages have also…
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Sees Large Increase in Short Interest
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) was the recipient of a significant increase in short interest in the month of October. As of October 15th, there was short interest totaling 18,161 shares, an…
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Stock Has Average Target Price of $48.90 According to Analysts
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) has been assigned an average recommendation of 'Moderate Buy' from the twelve ratings firms that are presently covering the company, MarketBeat Ratings reports. One equities research…
Congress can save America's unique history and boost the economy with just one move
One of us represents historic American studios that develop and distribute the world's greatest films and TV shows. Another represents 1.3 million hardworking Americans, including tens of thousands of drivers, transportation professionals, casting…
After Eli Lilly's Explosive Earnings Report, Is It Too Late to Buy the Stock?
Eli Lilly (LLY +3.19%), as a pharma giant, offers investors a certain sense of safety in any market environment. This is because, at all times, patients need their medical treatments. But this company has also presented investors with a spectacular…
Nifty 50 Ends Week 2% Higher as Choice Broking Sets 23,200 Hurdle
India's Nifty 50 rose 2% in the week ended Oct. 30, as Choice Broking Ltd. identified 23,200 as the index's next resistance level and set a higher range conditional on a break through it. The benchmark closed Friday at 23,053.10, gaining 116.35…
How Much You Need Invested for Dividends Alone to Cover a Nursing Home Bill
A year in a nursing home can cost more than many families earn. The national median for a semi-private room reached $129,575 a year, or $355 a day, according to the 2025 CareScout Cost of Care Survey. A private room averaged $127,750 in 2024. A…
Heart medication urgently recalled with pharmacists told to 'stop supplying
Heart medication is being urgently recalled in the UK with pharmacists told to “stop supplying immediately”. A batch of the oral solution of clopidogrel from Xeal Pharma has been recalled, according to the Medicines and Healthcare…
Google spinoff Isomorphic Labs is in a race to shake up the long, painful road to cancer-beating drugs
In a cavernous office in London's AI hub, a group of researchers is preparing to do battle with humanity's oldest enemy. Isomorphic Labs, a spinoff of Google DeepMind and the brainchild of AI pioneer Demis Hassabis, has an ambitious mission even by…
Anthropic's next big AI business is life sciences, from biotech research to drug discovery
Anthropic conquered coding. Now it's setting its sights on the human body. Anthropic's S-1 filing, which outlines its ambitions and financials ahead of a massive initial public offering next month, reads as a life-sciences manifesto. The maker of…
25,747 GSK PLC Sponsored ADR $GSK Shares Acquired by Summit Global Investments
Summit Global Investments grew its position in shares of GSK PLC Sponsored ADR (NYSE:GSK - Free Report) by 123.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The…
Park Avenue Securities LLC Buys 1,505 Shares of argenex SE $ARGX
Park Avenue Securities LLC increased its stake in shares of argenex SE (NASDAQ:ARGX - Free Report) by 157.4% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 2,461 shares of the company's stock after…
Vertex Pharmaceuticals Incorporated $VRTX Stock Sold by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.9% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 594,358 shares…
Mirae Asset Global Investments Co. Ltd. Makes New $116.63 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX
Mirae Asset Global Investments Co. Ltd. purchased a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 223,081 shares of…
Receive a Daily briefing on Pharma Industry News
Get Started